Spectrum of epilepsy with eyelid myoclonia: Delineation of disease subtypes from a large multicenter study
2022; Wiley; Volume: 64; Issue: 1 Linguagem: Inglês
10.1111/epi.17450
ISSN1528-1167
AutoresEmanuele Cerulli Irelli, Enrico Cocchi, Georgia Ramantani, Antonella Riva, Roberto Caraballo, Alessandra Morano, Loretta Giuliano, Tülay Yılmaz, Eleni Panagiotakaki, Francesca Felicia Operto, Beatriz G. Giráldez, Simona Balestrini, Katri Silvennoinen, Sara Casciato, Marion Comajuan, Francesco Fortunato, Anna Teresa Giallonardo, Rimma Gamirova, Antonietta Coppola, Giancarlo Di Gennaro, Angelo Labate, Vito Sofia, Gerhard Kluger, Antonio Gambardella, Dorothee G. A. Kasteleijn‐NolstTrenite, Betül Baykan, Sanjay M. Sisodiya, Alexis Arzimanoglou, Pasquale Striano, Carlo Di Bonaventura,
Tópico(s)Fetal and Pediatric Neurological Disorders
ResumoEpilepsy with eyelid myoclonia (EEM) has been associated with marked clinical heterogeneity. Early epilepsy onset has been recently linked to lower chances of achieving sustained remission and to a less favorable neuropsychiatric outcome. However, much work is still needed to better delineate this epilepsy syndrome.
Referência(s)